'Poison pill' won't disrupt Allergan deal: Ackman
April 23, 2014 at 07:40 AM EDT
Activist investor Bill Ackman told CNBC Tuesday that Allergan's adoption of a poison-pill defense does not necessarily make the takeover bid more difficult.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.